Pnc Financial Services Group, Inc. Rhythm Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $150 Billion
- Q2 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 92 shares of RYTM stock, worth $4,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92
Previous 101
8.91%
Holding current value
$4,724
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
178Shares Held
69.1MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$375 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$346 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$329 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$312 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$272 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.86B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...